Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Ravaud

Showing results (451-460 of 457) with videos related to

Pageof 46
Sort By:
You have reached the last page of results.This site can display upto 457 results.
Lancet (London, England)|June 15, 2026
SPIRIT 2025 statement: updated guideline for protocols of randomised trialsAn-Wen Chan, Isabelle Boutron, Sally Hopewell, et al.
Nature Medicine|April 28, 2025
SPIRIT 2025 statement: updated guideline for protocols of randomized trialsAn-Wen Chan, Isabelle Boutron, Sally Hopewell, et al.
JAMA|April 28, 2025
SPIRIT 2025 Statement: Updated Guideline for Protocols of Randomized TrialsAn-Wen Chan, Isabelle Boutron, Sally Hopewell, et al.
JCI Insight|January 23, 2026
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of deathOlivia Lenoir, Florence Morin, Anouk Walter-Petrich, et al.
RMD Open|October 29, 2015
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guideRaphaèle Seror, Simon J Bowman, Pilar Brito-Zeron, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
JAMA|July 6, 2021
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis, Manu Shankar-Hari, Claire L Vale, et al.
Pageof 46

Showing results (451-460 of 457) with videos related to

Sort By:
Pageof 46
You have reached the last page of results.This site can display upto 457 results.
Lancet (London, England)|June 15, 2026
SPIRIT 2025 statement: updated guideline for protocols of randomised trialsAn-Wen Chan, Isabelle Boutron, Sally Hopewell, et al.
Nature Medicine|April 28, 2025
SPIRIT 2025 statement: updated guideline for protocols of randomized trialsAn-Wen Chan, Isabelle Boutron, Sally Hopewell, et al.
JAMA|April 28, 2025
SPIRIT 2025 Statement: Updated Guideline for Protocols of Randomized TrialsAn-Wen Chan, Isabelle Boutron, Sally Hopewell, et al.
JCI Insight|January 23, 2026
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of deathOlivia Lenoir, Florence Morin, Anouk Walter-Petrich, et al.
RMD Open|October 29, 2015
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guideRaphaèle Seror, Simon J Bowman, Pilar Brito-Zeron, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
JAMA|July 6, 2021
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis, Manu Shankar-Hari, Claire L Vale, et al.
Pageof 46